GeneDx Holdings WGS Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by GeneDx Holdings in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: GeneDx Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about GeneDx Holdings's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GeneDx Holdings's investing cash flow?
- GeneDx Holdings (WGS) reported investing cash flow of -$17.26M in Q1 2026.
- How has GeneDx Holdings's investing cash flow changed year-over-year?
- GeneDx Holdings's investing cash flow decreased by 83.4% year-over-year, from -$9.41M to -$17.26M.
- What is the long-term trend for GeneDx Holdings's investing cash flow?
- Over 4 years (2021 to 2025), GeneDx Holdings's investing cash flow has grown at a 31.2% compound annual growth rate (CAGR), from -$20.79M to -$61.52M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.